Nishimura, Hideto
Ishii, Junnichi https://orcid.org/0000-0003-2695-0461
Takahashi, Hiroshi
Ishihara, Yuya
Nakamura, Kazuhiro
Kitagawa, Fumihiko
Sakaguchi, Eirin
Sasaki, Yuko
Kawai, Hideki
Muramatsu, Takashi
Harada, Masahide
Yamada, Akira
Tanizawa-Motoyama, Sadako
Naruse, Hiroyuki
Sarai, Masayoshi
Yanase, Masanobu
Ishii, Hideki
Watanabe, Eiichi
Ozaki, Yukio
Izawa, Hideo
Funding for this research was provided by:
JSPS KAKENHI (22K07487)
Article History
Received: 28 July 2024
Accepted: 20 November 2024
First Online: 4 December 2024
Declarations
:
: Dr Nishimura reports no conflicts. Dr J. Ishii received a research grant from Sysmex Corp. Mr. Takahashi, Mr. Ishihara, Mr. Nakamura, Mr. Kitagawa, and Dr Sakaguchi report no conflicts. Ms. Sasaki is an employee of Sysmex R&D Center Europe GmbH. Dr Kawai, Dr Muramatsu, Dr Harada, Dr Yamada, Dr Tanizawa-Motoyama, Dr Naruse, Dr Sarai, and Dr Yanase report no conflicts. Dr H. Ishii received honoraria from AstraZeneca KK, Bayer Pharmaceutical Co., Ltd., Boehringer Ingelheim Japan, Bristol-Myers Squibb Inc., Daiichi-Sankyo Pharma Inc., Kowa, MSD K. K., Mitsubishi Tanabe Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., Novartis Japan, Otsuka Pharmaceutical Co. Ltd., and Pfizer Japan Inc. Dr Watanabe reports no conflicts. Dr Ozaki received research grants from Takeda Pharmaceutical Co. Ltd., Sanofi KK, Mitsubishi Tanabe Pharma Corp., Otsuka Pharmaceutical Co. Ltd., Bayer Yakuhin, Ltd., Daiichi Sankyo Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., and Public Health Research Foundation. Dr Izawa received research grants from grant support through his institution from Bayer Yakuhin Ltd., Sumitomo Pharma Co. Ltd., PDR Pharma Co. Ltd., Biotronik Japan Co Ltd, Abbott Japan Co. Ltd., Boston Scientific Japan Co. Ltd., Japan Lifeline Co. Ltd., and Medtronic Japan Co. LtD., and honoraria for lectures from Otsuka Pharmaceutical Co. Ltd., Novartis Co. Cool., Eli Lilly Japan Co. Ltd., Bayer Yakuhin, Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., and Daiichi Sankyo Co. Ltd.